Hummingbird Bioscience

Hummingbird Bioscience is a pioneering healthcare startup based in Singapore. It operates with the mission to leverage cutting-edge technologies to decode biological complexities, thereby developing superior therapeutic antibodies that effectively combat life-threatening diseases. By decoding the immortal mysteries of human biology, it strives to revolutionize how diseases are treated and cured.

Since its inception, Hummingbird Bioscience has been committed to addressing the most urgent unmet medical needs. The company's advanced systems biology platform allows it to understand and manipulate disease-driving mechanisms in ways that were previously deemed impossible. This unique approach has led to the development of a robust pipeline of novel drug candidates, each precisely designed to inhibit specific disease targets.

Hummingbird Bioscience has built a reputation for valuable partnerships and collaborations, including corporations with research organizations, pharmaceutical giants, and cancer institutions. It is currently strategically aligned with Cancer Research UK, Amgen, and many more. Driven by a fearless pursuit of scientific discovery and a vision to shape a healthier future, Hummingbird Bioscience continues to push boundaries in the healthcare industry.

Company Details